Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank25
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P25
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -22.07% |
| 2023 | -62.78% |
| 2022 | -48.13% |
| 2021 | 61.48% |
| 2020 | 188.35% |
| 2019 | -12.83% |
| 2018 | 185.32% |
| 2017 | 120.67% |
| 2016 | -28.84% |
| 2015 | 72.35% |